LOADING
Comparing Pfizer Inc (PFE) and AT&T Inc (T) across the Health Care and Communication Services sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | PFE | T |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $162.4B | $198.3B |
| P/E Ratio | 21.0 | 9.3 |
| Forward P/E | 9.7 | 12.3 |
| PEG Ratio | 13.77 | 1.60 |
| EPS | $1.36 | $3.04 |
| Revenue Growth (YoY) | -1.2% | 3.6% |
| Profit Margin | 12.4% | 17.5% |
| Return on Equity | 8.9% | 18.8% |
| Dividend Yield | 6.13% | 3.92% |
| Beta | 0.41 | 0.58 |
| 52-Week High | $28.75 | $29.44 |
| 52-Week Low | $19.50 | $22.95 |
| Volume | -- | -- |
AT&T Inc is the larger company by market capitalization. AT&T Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Pfizer Inc offers a higher dividend yield for income investors. AT&T Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.